#genericdrugs
Drug Tariffs May Raise Prescription Costs: What Patients Should Know across U.S
A newly announced policy introducing tariffs on certain imported pharmaceuticals could gradually increase prescription drug costs for patients across the United States. The measure applies primarily to brand-name medications that remain under patent, along with some of their active ingredients, with tariff rates potentially reaching up to 100 percent depending on compliance with pricing or domestic production conditions. While generic medications and biosimilars are currently exclud
Drug Tariffs May Raise Prescription Costs: What Patients Should Know across U.S
A newly announced policy introducing tariffs on certain imported pharmaceuticals could gradually increase prescription drug costs for patients across the United States. The measure applies primarily to brand-name medications that remain under patent, along with some of their active ingredients, with tariff rates potentially reaching up to 100 percent depending on compliance with pricing or domestic production conditions. While generic medications and biosimilars are currently exclud
Trump announces 100 percent tariffs on branded drugs, India pharma may face big hit
Washington: US President Donald Trump has announced sweeping new tariffs on imported pharmaceutical products, a move that could trigger widespread consequences for the global drug trade and India’s pharmaceutical sector in particular. Effective October 1, 2025, Washington will impose tariffs of up to 100 percent on branded and patented pharmaceutical drugs unless the manufacturing companies are building their production facilities within the United States. The president emphasized that
Trump announces 100 percent tariffs on branded drugs, India pharma may face big hit
Washington: US President Donald Trump has announced sweeping new tariffs on imported pharmaceutical products, a move that could trigger widespread consequences for the global drug trade and India’s pharmaceutical sector in particular. Effective October 1, 2025, Washington will impose tariffs of up to 100 percent on branded and patented pharmaceutical drugs unless the manufacturing companies are building their production facilities within the United States. The president emphasized that









